Thursday, December 11, 2014
This conference has already taken place.
Description
For pricing information, see pricing tab below.
Dates and Times
Start: 12/11/2014 12:00 AM
End: 12/11/2014 12:00 AM
Objectives
1. Identify new pathophysiology of type 2 Diabetes
2. Describe the role of GLP-1 Analogues, DDP IV Inhibitors and SGLT2 Receptor Inhibitors in managing Type 2 Diabetes
3. Explain effective strategies in selecting new anti-diabetic medications
4. Assess controversies surrounding the use of GLP-1 Analogues, DDP IV Inhibitors and SGLT2 Receptor Inhibitors
Pricing
Tier | Price |
---|---|
All | $10.00 |
Speakers
Location
The Fawcett Center
2400 Olentangy River Road
Columbus, OH 43201
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.